The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III study to compare efficacy and safety of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with metastatic or recurrent gastric cancer after failure of first-line chemotherapy (DREAM).
 
Sang Cheul Oh
No Relationships to Disclose
 
Min-Hee Ryu
Honoraria - Novartis; Roche Pharma AG
Consulting or Advisory Role - Novartis; Roche Pharma AG
 
Se Hoon Park
No Relationships to Disclose
 
Baek-Yeol Ryoo
No Relationships to Disclose
 
Sook Ryun Park
No Relationships to Disclose
 
Jong Gwang Kim
No Relationships to Disclose
 
Jin Won Kim
No Relationships to Disclose
 
Ik-Joo Chung
No Relationships to Disclose
 
Young Iee Park
No Relationships to Disclose
 
Sun Young Rha
No Relationships to Disclose
 
Myoung Joo Kang
No Relationships to Disclose
 
Jae Yong Cho
No Relationships to Disclose
 
Seok Yun Kang
No Relationships to Disclose
 
Young Seon Hong
No Relationships to Disclose
 
Byung-Ho Nam
No Relationships to Disclose
 
Yeong-Woo Jo
No Relationships to Disclose
 
Koung Eun Yoon
No Relationships to Disclose
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech